AP1707A - Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same. - Google Patents

Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same.

Info

Publication number
AP1707A
AP1707A APAP/P/2002/002485A AP2002002485A AP1707A AP 1707 A AP1707 A AP 1707A AP 2002002485 A AP2002002485 A AP 2002002485A AP 1707 A AP1707 A AP 1707A
Authority
AP
ARIPO
Prior art keywords
oestrogen
progesterone
producing
same
relates
Prior art date
Application number
APAP/P/2002/002485A
Other versions
AP2002002485A0 (en
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542725&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP1707(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of AP2002002485A0 publication Critical patent/AP2002002485A0/en
Application granted granted Critical
Publication of AP1707A publication Critical patent/AP1707A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

The invention relates to the field of chemistry and more particularly, to that of therapeutic chemistry. The invention relates particularly to novel contraceptive compositions formed from a progestative agent and an oestrogen. The invention relates specifically to novel pharmaceutical contraceptive compositions characterised in that they contain, as active principles, a nomegestrol ester and oestradiol in combination or as a mixture with an inert, non-toxic, pharmaceutically acceptable vehicle which is suitable for oral administration.
APAP/P/2002/002485A 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same. AP1707A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002587 WO2001030355A1 (en) 1999-10-25 1999-10-25 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
PCT/FR2000/002952 WO2001030358A1 (en) 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same

Publications (2)

Publication Number Publication Date
AP2002002485A0 AP2002002485A0 (en) 2002-06-30
AP1707A true AP1707A (en) 2007-02-26

Family

ID=9542725

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002485A AP1707A (en) 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same.

Country Status (21)

Country Link
EP (2) EP1227815A1 (en)
JP (1) JP5484646B2 (en)
KR (1) KR100549625B1 (en)
CN (1) CN1205936C (en)
AP (1) AP1707A (en)
AU (1) AU784478B2 (en)
BR (1) BR0014952A (en)
CA (1) CA2388857C (en)
CR (1) CR6627A (en)
CZ (1) CZ301982B6 (en)
ES (1) ES2565688T3 (en)
HK (2) HK1048600A1 (en)
HU (1) HU230467B1 (en)
IL (2) IL149141A0 (en)
MX (1) MXPA02004083A (en)
NO (1) NO330885B1 (en)
NZ (1) NZ518308A (en)
OA (1) OA12071A (en)
RU (1) RU2258512C2 (en)
WO (2) WO2001030355A1 (en)
ZA (1) ZA200203399B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (en) 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
WO2001030356A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
FR2814074B1 (en) * 2000-09-15 2003-03-07 Theramex NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
KR100975350B1 (en) * 2002-11-29 2010-08-12 재단법인서울대학교산학협력재단 Transgenic cloned cow producing human lactoferricin and method for producing the same
BRPI0512991A (en) * 2004-07-07 2008-04-22 Wyeth Corp use of a progestin, pharmaceutically useful kit adapted for daily oral administration, and method of contraception in a female of childbirth
US8663681B2 (en) * 2005-05-26 2014-03-04 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
CN103877059A (en) * 2014-03-26 2014-06-25 邵娜 Nomegestrol acetate tablet and preparation process thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179A1 (en) * 1996-10-08 1998-04-10 Theramex NOVEL HORMONONAL COMPOSITION AND USE THEREOF

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
EP0559240B1 (en) 1987-09-24 2001-12-05 Jencap Research Limited Contraceptive packages containing oestrogen and progestin
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5532416A (en) 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE4344462C2 (en) 1993-12-22 1996-02-01 Schering Ag Composition for contraception
FR2737411B1 (en) * 1995-08-01 1997-10-17 Theramex NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES
DE19529767A1 (en) 1995-08-12 1997-02-13 Huels Chemische Werke Ag Amphiphilic compounds with several hydrophilic and hydrophobic groups based on amino succinic acid derivatives
US5902914A (en) 1995-08-14 1999-05-11 Alliedsignal Inc. Process for the preparation of halogenated alkanes
AUPN479995A0 (en) 1995-08-15 1995-09-07 Leon Kruss Technology Pty Limited Lightweight cementitious composition
US5654494A (en) 1995-08-18 1997-08-05 Alliedsignal Inc. Process for the manufacture of 1,1,1,2-tetrafluoroethane
US5530167A (en) 1995-08-21 1996-06-25 Eastman Chemical Company Process for the preparation of 1,4-butenediol
US5820059A (en) 1995-10-02 1998-10-13 Nsk Ltd. Retractor for seat belt
DE19536742A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle
DE29515703U1 (en) 1995-10-02 1996-02-08 Foehl Artur Rotary drive device for a belt tensioner
DE19536744A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade with interchangeable wiper rubber for a vehicle wiper
DE19536745A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle, in particular a motor vehicle
EP0770338B1 (en) 1995-10-23 2002-09-25 Honda Access Corp. Cap body of a helmet
DE19540253C2 (en) 1995-10-28 1998-06-04 Jenapharm Gmbh Multi-phase preparation for contraception based on natural estrogens
DE19549264A1 (en) 1995-12-23 1997-06-26 Schering Ag Contraception procedure and kit
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
GB9621990D0 (en) 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19705229C2 (en) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE69827017T2 (en) 1997-08-27 2006-03-09 Ortho-Mcneil Pharmaceutical, Inc. COMBINATIONS OF ENDOMETRICALLY PROTECTED AND ENDOMETRICALLY ATROPHOSED AGENTS WITH ESTROGENIC IN ORAL CONCENTRATION PREVENTION
DE19739916C2 (en) 1997-09-11 2001-09-13 Hesch Rolf Dieter Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
WO1999013882A1 (en) 1997-09-12 1999-03-25 American Home Products Corporation Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179A1 (en) * 1996-10-08 1998-04-10 Theramex NOVEL HORMONONAL COMPOSITION AND USE THEREOF

Also Published As

Publication number Publication date
CN1382054A (en) 2002-11-27
EP2020236A1 (en) 2009-02-04
AP2002002485A0 (en) 2002-06-30
EP2020236B1 (en) 2016-01-27
IL149141A0 (en) 2002-11-10
AU1033501A (en) 2001-05-08
CZ20021426A3 (en) 2002-08-14
OA12071A (en) 2006-05-04
ZA200203399B (en) 2004-02-09
KR100549625B1 (en) 2006-02-08
CA2388857C (en) 2011-06-07
NO20021948L (en) 2002-06-25
HK1048600A1 (en) 2003-04-11
CN1205936C (en) 2005-06-15
IL149141A (en) 2008-06-05
HUP0203443A2 (en) 2003-01-28
CA2388857A1 (en) 2001-05-03
NZ518308A (en) 2006-01-27
RU2258512C2 (en) 2005-08-20
NO20021948D0 (en) 2002-04-25
ES2565688T3 (en) 2016-04-06
PL354518A1 (en) 2004-01-26
MXPA02004083A (en) 2003-08-20
JP5484646B2 (en) 2014-05-07
HUP0203443A3 (en) 2003-12-29
JP2003518013A (en) 2003-06-03
NO330885B1 (en) 2011-08-08
CR6627A (en) 2008-06-18
AU784478B2 (en) 2006-04-13
KR20020073333A (en) 2002-09-23
HK1129564A1 (en) 2009-12-04
WO2001030355A1 (en) 2001-05-03
RU2002113654A (en) 2004-01-27
HU230467B1 (en) 2016-07-28
BR0014952A (en) 2003-07-29
WO2001030358A1 (en) 2001-05-03
CZ301982B6 (en) 2010-08-25
EP1227815A1 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
US10940205B2 (en) Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
EP0911029A3 (en) Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
CA2366702A1 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
HUP0204137A2 (en) Pharmaceutical composition comprising fulvestrant
CA2518910A1 (en) Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
EP0966966A3 (en) Nefazodone dosage form
CA2487722A1 (en) New etonogestrel esters
AP1707A (en) Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same.
AU777704B2 (en) Hormonal composition based on a progesterone and an oestrogen and use thereof
AR009113A1 (en) A CONTRACEPTIVE PRODUCT TO STOP OVULATION IN WOMEN DURING THEIR PERIOD OF OVARIAN ACTIVITY
JP2003522121A5 (en)
RU2449796C9 (en) Pharmaceutical combination of ethynylestradiol and drospirenone for using as contraceptive
Garza-Flores Pharmacokinetics of once-a-month injectable contraceptives
AU781836B2 (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (HRT)
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
MXPA05003364A (en) 17beta-ESTRADIOL/LEVONORGESTREL TRANSDERM PATCH FOR HORMONE REPLACEMENT THERAPY.
AU729898B2 (en) Transdermal therapeutic system having an active compound combination comprising oestriol
EP1178807B1 (en) Use of org 33245 in combined intermittent hormone therapy and contraception
WO2002041875A3 (en) Method for producing readily soluble medicament formulations and corresponding formulations
HUP0203655A2 (en) Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds
US20080280861A1 (en) Method of Female Contraception and a Kit For Use Therein
RU99109091A (en) HORMONAL COMPOSITION CONSISTING OF ESTROGENIC COMPOUND AND PROGESTERON COMPOUND
WO2000059447A2 (en) Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding
TH55261B (en) The use of biogenic estrogen sulfamate in hormone replacement therapy.
GB2310600A (en) Pharmaceutical composition containing gestrinone and use thereof